HEC585 not checked

Sunshine Lake Pharma Co., Ltd.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
3 active
7 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“taking HEC585 dose A orally once daily, up to 24 weeks in main stage (if applicable); up to 96 weeks in extended stage”In the company’s words, NCT05139719 on ClinicalTrials.gov
Tested for
Idiopathic Pulmonary Fibrosis (IPF), Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)
Main trialPhase 3
“A multicenter, parallel, randomized, placebo (double-blind) and pirfenidone (open-label) controlled Phase III clinical trial to evaluate the efficacy and safety of HEC585 in patients with idiopathic pulmonary fibrosis (IPF)”In the company’s words, NCT07082842 on ClinicalTrials.gov

Other drugs for Idiopathic Pulmonary Fibrosis (IPF)

All 42 drugs for Idiopathic Pulmonary Fibrosis (IPF)

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials7

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 15 Jan 2031 Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF
Phase 2Active, not recruiting 16 Jul 2025 Phase ll Study of HEC585 in Patients With IPF
Phase 2Recruiting Dec 2026 A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients
Phase 1Completed 23 Aug 2021 Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects
Phase 1Completed 30 Nov 2021 Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy Subjects
Phase 1Completed 30 Nov 2021 To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers
Phase 1Completed 14 Aug 2022 Study on the Body Mass Balance and Biotransformation of [14C]-HEC585
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow HEC585

Following is part of Solo: you see every change to HEC585 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in